A latest report has been added to the wide database of Conjunctivitis Market by Infinium Global Research. This report studies the Conjunctivitis Market by disease type (bacterial conjunctivitis, viral conjunctivitis, allergic conjunctivitis) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Conjunctivitis Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Conjunctivitis Market. According to the report the Global Conjunctivitis Market is projected to grow at a CAGR of 2.1% in terms of value over the period of 2017-2023.
Get a Sample Request
Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or ultraviolet light. Conjunctivitis is an extremely common eye problem because the conjunctiva is continually exposed to microorganisms and environmental agents that can cause infections or allergic reactions. It can also affect one or both eyes and, if caused by infection, can be very easily transmitted to others during close physical contact, particularly among children in a daycare center. Thus, people diagnosed with conjunctivitis are recommended not to travel public places for that period of time.
Increasing awareness among patient population about pink eye disease, entry of new drugs and unmet need for viral conjunctivitis are considered to be the key factors driving the growth of this market. Unfavorable government regulations, expiring drug patents of major blockbusters and the growing demand for antibacterial drugs has impacted the demand for branded drugs are the key restraining factors for the growth of this market. Since, there are no approved drugs for the treatment of viral conjunctivitis, many companies are developing drugs which are expected to aid in the treatment of viral conjunctivitis and their effect will turn into a prominent opportunity to promote growth of this market over the forecast period. Moreover, loss of patent exclusivities and increasing demand for generic antibacterial drugs over branded drugs are the major challenges faced by this market.
The report on global conjunctivitis market covers segments such as, disease type. On the basis of disease type the global conjunctivitis market is categorized into bacterial conjunctivitis, viral conjunctivitis and allergic conjunctivitis.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global conjunctivitis market such as, Akorn, Alcon, Allergan, Inc., Bausch & Lomb, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Nicox, NovaBay and Ocular Therapeutix.
Make an Enquiry
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global conjunctivitis market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of conjunctivitis market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the conjunctivitis market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the conjunctivitis market to understand the present and future trends in this market and formulate their strategies accordingly.
Table of Contents:-
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Conjunctivitis Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Conjunctivitis Market
4. Global Conjunctivitis Market by Disease Type
4.1. Bacterial Conjunctivitis
4.2. Viral Conjunctivitis
4.3. Allergic Conjunctivitis
5. Global Conjunctivitis Market by Region 2017-2023
5.1. North America
5.1.1. North America Conjunctivitis Market by Disease Type
5.1.2. North America Conjunctivitis Market by Country
5.2.1. Europe Conjunctivitis Market by Disease Type
5.2.2. Europe Conjunctivitis Market by Country
5.3.1. Asia-Pacific Conjunctivitis Market by Disease Type
5.3.2. Asia-Pacific Conjunctivitis Market by Country
5.4.1. RoW Conjunctivitis Market by Disease Type
5.4.2. RoW Conjunctivitis Market by Sub-region
6. Company Covered
6.3. Allergan, Inc.
6.4. Bausch & Lomb
6.5. Eleven Biotherapeutics
6.6. Griffin Discoveries
6.10. Ocular Therapeutix
Click the Below Full Report Link